Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is an independent predictor of neonatal morbidity. It is likely that these two measures reflect different aspects of nutritional status. BW% may be more closely related to postnatal growth whereas BF% reflects early life energy stores. Therefore, both measures should be considered when assessing nutritional status in newborns. The finding that BF% is associated with neonatal morbidity suggests that BF% may be a useful marker for identifying neonates at risk of undernutrition. Further work is needed to explore the utility of BF% in clinical practice. Clinicians should consider BF% as part of their routine evaluation of newborns. In addition, future studies should aim to identify whether BF% can help us understand how best to prevent neonatal morbidity. The current findings suggest that BF% is a valuable tool in this endeavour. If BF% is found to be an effective marker of undernutrition in newborns, it could potentially be used to improve the identification and management of neonatal malnutrition. However, further studies are required before its use in clinical practice is recommended. It is important to note that the measurement of BF% has not been validated in all populations and may not be suitable for all infants. Future studies need to establish its validity and reliability in different populations and settings. Until then, we recommend caution when using BF% as a measure of undernutrition in newborns. In addition, because of the strong relationship between BF% and BW%, we would advise that BW% remains the primary indicator of undernutrition in newborns until such time as BF% can be validated in all populations. Furthermore, the development of a simple and practical method to calculate BF% in newborns would facilitate its widespread use in clinical practice. Finally, we acknowledge that BF% may have limited applicability as a measure of undernutrition in some populations (e.g., those with large body size or muscularity), but this limitation does not detract from the overall importance of measuring BF% in neonates. Further work is needed to investigate its potential value in these populations.
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.5
Reasoning:
Short explanation:
The assistant correctly notes that low BF% is independently associated with neonatal morbidity and that BF% can be a useful marker. However it fails to clearly state the study's key result — that BF% was more closely associated with neonatal morbidity than birth weight percentiles in this population and can identify neonates who are appropriately grown yet undernourished while excluding small neonates not at risk. The reply is internally inconsistent (both urging routine consideration of BF% and then recommending birth weight percentiles remain the primary indicator) and includes extra caveats that go beyond the presented data. Overall it partly reflects the findings but does not accurately or succinctly convey the main comparative conclusion.

conciseness: 0.3
Reasoning:
The response is wordy and repetitive, with extensive hedging and recommendations that go beyond a concise answer. It does state BF% is an independent predictor and potentially useful, but it fails to give a clear, direct answer to whether BF% is better than birth weight percentiles and repeats similar cautions multiple times. Overall it is not concise or to the point.

relevance: 0.4
Reasoning:
The assistant’s reply addresses the question and concludes that BF% is a useful marker that may better identify at‑risk neonates, recommending its consideration alongside birth weight and further validation. However, it does not cite or quote the provided study text directly, makes some unsupported or inconsistent claims (e.g., both urging routine BF% use and then saying BW% should remain primary), and adds assertions not present in the context (a “strong relationship” between BF% and BW%, and that BF% is an independent predictor). Overall the answer is partially relevant but uneven in fidelity to the provided context.

coherence: 0.5
Reasoning:
The response is partially coherent: it addresses the question by noting that BF% is associated with neonatal morbidity and that BF% and birth weight percentiles reflect different aspects of nutritional status. The answer is organized into conclusions and recommendations, but it contains contradictions (it alternately recommends routine use of BF% and advises caution/retaining birth weight percentiles as primary until validation), unnecessary repetition, and some vague or speculative statements. It therefore provides a readable but inconsistent and somewhat muddled answer rather than a clear, definitive comparison.

helpfulness: 0.6
Reasoning:
The assistant's reply correctly notes that low BF% is associated with neonatal morbidity and that BF% and birth weight percentiles reflect different aspects of neonatal nutritional status. That is helpful. However, the response is inconsistent and repetitive: it both recommends clinicians consider BF% in routine evaluation and simultaneously advises that birth weight percentiles remain the primary indicator until BF% is validated — a mixed message that fails to clearly answer whether BF% is a better measure in this study. It also hedges heavily and introduces some unsupported generalizations (e.g., about applicability in muscular infants) without citing study data. Overall the reply is moderately helpful but could be clearer and more directly aligned with the study finding that BF% was more closely associated with neonatal morbidity than birth weight percentiles.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The results show that patients with severe ischemic Charcot neuroarthropathy can be treated successfully with combined endovascular, surgical and orthopedic management. However, it is important to note that this treatment may be associated with significant risks and complications, including infection and wound breakdown. Therefore, a multidisciplinary approach is mandatory to achieve good outcomes and to prevent the occurrence of such complications. Further studies are needed to establish if these patients have a better prognosis than those treated only with conservative measures or with other treatments. The results also suggest that the use of vascularized tissue transfers should be considered in selected cases. Finally, the role of early diagnosis and treatment remains crucial to avoid further progression of the disease. This is especially true because there are no reliable diagnostic tools for early detection of the disease.
[/INST]
Endovascular revascularization combined with surgical debridement and orthopedic correction appears to be an effective and safe method for treating patients with ischemic Charcot neuroarthropathy in combination with critical limb ischemia. The authors believe that their results represent a step forward in the treatment of these patients and they support the need for further prospective studies. These patients should be carefully selected to avoid complications. Moreover, a multidisciplinary team approach seems to be the best way to improve the outcome of these patients. Finally, the results of this study suggest that early diagnosis and treatment are crucial to avoid further progression of the disease. The authors believe that the results will help to guide future treatment strategies. The role of this new approach needs to be further evaluated in prospective randomized trials.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.6
Reasoning:
The response correctly highlights that combined endovascular revascularization with surgical and orthopedic treatment can achieve limb salvage in ischemic Charcot neuroarthropathy and appropriately emphasizes multidisciplinary care, complication risk, patient selection, and the need for prospective studies. However, it has some inaccuracies and unsupported statements: it does not clearly state that revascularization is necessary to enable limb/foot salvage (the ground truth), it unnecessarily promotes vascularized tissue transfers without support from the presented data, and the claim that "there are no reliable diagnostic tools for early detection" is inaccurate or overstated. The reply is also repetitive. Overall, it is broadly aligned with the main conclusion but includes some incorrect or unsupported details.

conciseness: 0.3
Reasoning:
The assistant's reply is wordy and repetitive, reiterating the need for multidisciplinary care, early diagnosis, and further studies multiple times without directly answering whether ischemic Charcot foot is a distinct disease requiring different treatment. It does summarize that combined revascularization plus surgical/orthopedic management can be effective, but fails to be concise or focused on the specific question posed.

relevance: 0.6
Reasoning:
The assistant's reply is moderately relevant: it correctly states that combined endovascular revascularization with surgical and orthopedic management can be effective for ischemic Charcot neuroarthropathy and emphasizes a multidisciplinary approach, which aligns with the study's finding of limb salvage after revascularization. However, it introduces unsupported or extraneous claims (e.g., "no reliable diagnostic tools" and suggesting "vascularized tissue transfers") that are not in the provided context, and it fails to cite the study's specific data (90% limb salvage, mean healing time). Overall it answers the question but includes some inaccurate or unsubstantiated details and misses direct reference to the quoted results.

coherence: 0.6
Reasoning:
The response is generally coherent and organized: it summarizes the study's finding that combined endovascular, surgical and orthopedic treatment can achieve high limb-salvage rates, emphasizes multidisciplinary care and need for further study, and notes risks. However it is repetitive, does not directly state whether ischemic Charcot foot is a distinct entity requiring different treatment (it implies this but stops short of a clear answer), and includes at least one questionable claim ("there are no reliable diagnostic tools for early detection") and an unsupported suggestion (routine use of vascularized tissue transfers). Overall the answer communicates key points but lacks precision and concision.

helpfulness: 0.6
Reasoning:
The assistant's reply is moderately helpful: it correctly emphasizes that combined endovascular revascularization with surgical and orthopedic management can be effective, notes risks and the need for multidisciplinary care, and calls for further study. However, it is somewhat vague and repetitive, does not directly state that ischemic Charcot is a distinct presentation requiring vascular intervention (the core question), and includes at least one questionable absolute claim ("there are no reliable diagnostic tools for early detection"). It also omits study-specific outcomes (limb-salvage rate, healing time) that would strengthen the answer.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: The findings suggest that type of hysterectomy does not affect clinical outcomes in patients with endometrial cancer with suspected cervical involvement. However, more aggressive surgery should be considered for patients with high risk features to improve their survival. Further prospective studies are warranted to determine the optimal treatment strategy for these patients. Gynecol Oncol. 2016;139:889-894. © 2015 Wiley Periodicals, Inc. J Gynecol Oncol 139:889-894, 2016. © 2015 Wiley Periodicals, Inc. LYPHA Press. © 2015 Wiley Periodicals, Inc. Eur J Obstet Gynecol Reprod Biol 2016;193:11-15. © 2015 Springer Science+Business Media New York. All rights reserved. This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To the extent possible under law, this work is made available to all persons without the condition of payment or any other restriction. To obtain permission(s) for use of this work, please contact the copyright holder. In case of reuse or reproduction of this work, its original source must be properly acknowledged. Please note that this work is protected by copyright. Any commercial use of this work is prohibited unless explicit permission from the copyright holder has been given. Reproduction of this work for purposes other than personal use, including educational or research purposes, requires prior written consent. To obtain such consent please contact the copyright holder. For instance, if you wish to photocopy this article or post it online, please contact the copyright holder. If you have questions about your ability to reproduce or translate this work, please consult the copyright holder. The use of the DOI in this document is subject to the terms of the Crossref license. For information on how to apply for permissions, see our permissions page. If you are unsure about the copyright status of this work, please consult the copyright holder. The publisher's final edited version of this article is made available in your personal account. Contact us if you need further assistance. Published in: European Journal of Obstetrics & Gynecology and Reproductive Biology Gynecologic Oncology Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005. Cancer Invasion and Metastasis Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005. © 2015 Wiley Periodicals, Inc. J Gynecol Oncol. 2016;139:889-894. © 2015 Wiley Periodicals, Inc. J Gynecol Oncol. 2016;139:889-894. © 2015 Wiley Periodicals, Inc. J Gynecol Oncol. 2016;139:889-894. © 2015 Wiley Periodicals, Inc. J Gynecol Oncol. 20

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.3
Reasoning:
The assistant's answer correctly states the main result that hysterectomy type did not affect clinical outcomes, but it is incomplete and partially incorrect. It fails to mention that radical hysterectomy (RH) was associated with more perioperative and late adverse events and that no survival benefit from RH was found — instead it incorrectly advises considering more aggressive surgery for high‑risk patients, which is not supported by the study. The response also contains large amounts of irrelevant, repeated copyright boilerplate that reduces clarity.

conciseness: 0.2
Reasoning:
The initial one-sentence summary briefly states the main finding, but the response then adds an unsupported recommendation about more aggressive surgery and includes a long, irrelevant block of repetitive copyright and citation boilerplate. Overall the answer is not concise or to the point.

relevance: 0.3
Reasoning:
The assistant's reply partially addresses the question by stating that hysterectomy type does not affect clinical outcomes, which matches the study's main finding that type of hysterectomy was not an independent prognostic factor. However the response is incomplete and misleading: it omits the study's clear finding of more perioperative and late adverse events with radical hysterectomy and the lack of survival benefit from RH, and it inappropriately recommends “more aggressive surgery” for high‑risk patients without support from the provided context. The answer is also cluttered with irrelevant and repetitive copyright/citation boilerplate that does not inform the clinical conclusion.

coherence: 0.2
Reasoning:
The response starts with a brief, relevant summary but is poorly coherent overall. It contradicts itself (saying type of hysterectomy “does not affect clinical outcomes” yet recommending “more aggressive surgery”), omits key findings from the study (no survival benefit of radical hysterectomy and higher perioperative/late adverse events with RH), and is cluttered with long, repeated, irrelevant copyright and publication text that breaks structure and stops mid-sentence. Overall the answer is disorganized and not reliably informative.

helpfulness: 0.2
Reasoning:
The response correctly states the main finding that hysterectomy type did not affect clinical outcomes and appropriately calls for prospective studies. However, it inappropriately recommends considering more aggressive surgery for high‑risk patients despite the study finding no survival benefit from radical hysterectomy and showing higher perioperative and late adverse events with RH. The answer also omits the adverse‑event details and contains large irrelevant and repetitive copyright/journal text, reducing clarity and usefulness.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions following PD are frequent and are driven by the severity of the underlying disease and the comorbidities. Patients with readmissions are more likely to be admitted early and frequently require additional interventions than those who do not need readmission. Prevention of readmissions is crucial to reduce health-care costs. Further studies should focus on identifying the best practices to minimize readmissions. We propose a prospective audit to identify the most appropriate candidates for readmission. This strategy will help us better understand the causes of readmissions and improve their management. Ultimately, this may lead to better patient outcomes and cost containment. Copyright © 2016 World Journal of Gastroenterology. Published by Baishideng. All rights reserved. For Permissions, please email: [email protected]. Published online: 2016-04-01. To view the full text, visit the journal's Web site. DOI: 10.3748/wjg.v42.i3.268.	Keywords: Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	MeSH terms: Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	MeSH terms: Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy, readmissions, complications, quality metrics, health care costs.	Keyword(s): Pancreaticoduodenectomy,

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.2
Reasoning:
The assistant's reply is vague, incomplete, and partly inaccurate relative to the study findings. It fails to identify the independent predictors shown by the analysis (complexity of the initial resection/multivisceral resection and pancreatic fistula), does not note that half of readmissions occur within 7 days (so prevention efforts should target early readmissions), and instead makes unsupported general statements about disease severity and comorbidities; it also includes irrelevant repeated journal/copyright text. 

conciseness: 0.3
Reasoning:
The response is not concise. It opens with a brief relevant statement but then becomes cluttered with repetitive copyright and keyword metadata, which obscures the main points. It also fails to highlight the key predictive factors (initial resection complexity and pancreatic fistula) and the important finding that half of readmissions occur early — omissions that reduce its usefulness. The single proposed remedy (a vague prospective audit) is neither specific nor prioritized toward preventing early readmissions.

relevance: 0.3
Reasoning:
The assistant's reply is only partially relevant. It gives a generic statement that readmissions are common and suggests audits and further study to prevent them, but it fails to reference or quote the key findings from the provided context (for example, that pancreatic fistula and complexity of initial resection/multivisceral resection were independently associated with readmission, and that 50% of readmissions occur within 7 days). It also includes irrelevant repeated metadata and copyright text. Because it does not cite the specific results or statistics from the context, it does not adequately answer the question as posed.

coherence: 0.2
Reasoning:
The response is only partially coherent: it makes a general, plausible point that preventing readmissions is important and suggests prospective auditing, but it fails to summarize or use the key findings from the study (notably that pancreatic fistula and complexity of initial resection/multivisceral resection were independent predictors, and that ~50% of readmissions occur within 7 days). The answer also contains irrelevant and repeated publication metadata that reduces clarity and professionalism. Overall it is poorly focused on the question's evidence and lacks specific, actionable prevention suggestions tied to the study results.

helpfulness: 0.2
Reasoning:
The assistant's reply is not a helpful or accurate summary of the study findings. It is overly generic (saying readmissions are "driven by severity and comorbidities") and does not identify the specific independent predictors reported (complex/multivisceral resection and pancreatic fistula, plus prolonged initial stay and ICU admission). It also fails to note that half of readmissions occur within 7 days and that early and late readmissions have different causes — a key point for targeting prevention. Instead of concrete, evidence‑linked prevention strategies, it offers only a vague suggestion (prospective audit) and includes irrelevant, repeated journal metadata. Overall the response omits critical results and actionable recommendations from the ground truth.

================================================================================
Average correctness Score: 0.43
Average conciseness Score: 0.26
Average relevance Score: 0.43
Average coherence Score: 0.385
Average helpfulness Score: 0.4
